Biosimilar epoetin for the management of chemotherapy-induced anemia in elderly patients

Overview of attention for article published in OncoTargets and therapy, October 2016

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age and source

Mentioned by

twitter: 1 X user

Citations

dimensions_citation: 4 Dimensions

Readers on

mendeley: 13 Mendeley

Summary X Dimensions citations

So far, Dimensions has found 4 publications that cite this research output.

4

The most recent citing publications are shown below. View all 4 publications that cite this research output on Dimensions.

Efficacy and Safety of Supportive Care Biosimilars Among Cancer Patients: A Systematic Review and Meta-Analysis

Article in BioDrugs (June 2019)

Use and costs of originator and biosimilar erythropoiesis-stimulating agents in the treatment of chemotherapy-induced anemia: real-world evidence from an Italian hospital

Article in Future Oncology (November 2018)

Iron status in the elderly: A review of recent evidence

Article in Mechanisms of Ageing and Development (July 2018)